确定性放化疗联合抗程序性死亡受体1（PD-1）免疫疗法治疗不可切除食管鳞状细胞癌：一项多中心真实世界研究
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study.
作者信息
Yang Xiongtao, Wang Xiaomin, Xiao Qin, Ge Xiaolin, Yu Nuo, Li Jiao, Feng Guojie, Zheng Ziyu, Jiang Yingying, Lu Lin, Xia Xiaojie, Deng Lei, Zhang Tao, Wang Wenqing, Liu Wenyang, Wang Jianyang, Xiao Zefen, Zhou Zongmei, Bi Nan, Wang Hui, Chen Cheng, Wang Xin
机构信息
Department of Oncology, Beijing Changping Hospital, Beijing, China.
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
Cancer Biol Ther. 2025 Dec;26(1):2504726. doi: 10.1080/15384047.2025.2504726. Epub 2025 May 14.
Abstract
Trial no. NCT04821778 registered in ClinicalTrials.gov.
摘要
试验编号NCT04821778已在ClinicalTrials.gov上注册。
Zotero 插件